Navigation Links
A Vaccine for the impending pandemic Avian Influenza

All influenza viruses of the type A, including those causing seasonal epidemics of human influenza//, are genetically labile and well adapted to elude host defenses. The tendency of influenza viruses to undergo frequent and permanent antigenic changes necessitates constant monitoring of the global influenza situation and annual adjustments in the composition of influenza vaccines. Due to this tendency of mutation, avian influenza mixed with a human flu, and was thus able to infect humans through direct contact with birds.

According to the World Health Organization, of the 115 people in four Asian countries who have been infected with H5N1 from late 2003 through 2005, 59 have died. Vaccines are the principal medical intervention for protecting individuals against pandemic influenza. If available rapidly and in sufficient quantities, they can reduce the morbidity and mortality in pandemic situations.

According to a news posted on Sept 28, 2005, government scientists at the US National Institute of Allergy and Infectious Diseases (NIAID) announced results from initial clinical trials of a vaccine being developed to protect humans against infection with H5N1 avian influenza. NIAID and MedImmune have joined forces to develop potential pandemic influenza vaccines. HHS Secretary Mike Leavitt today announced that NIAID and MedImmune Inc. have signed a cooperative research and development agreement for the development of vaccines against avian influenza viruses that have the potential to cause pandemics. Speaking of pandemic flu as an urgent health challenge, HHS

Secretary Mike Leavitt said. “This agreement will help speed the process of developing vaccines we will need to fight an outbreak if the avian flu starts to spread rapidly through the human population.” As per the agreement, scientists will add selected genes from avian flu viruses with pandemic potential into a weakened human flu virus to create several attenuated, live virus v accines candidates.

Although there has been an incredible and alarming rise in human cases of bird flu, causing increasing fear of a global pandemic, there seems to be a strong resolve in the scientific community to combat this impending and much dreaded pandemic.
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . The new ... respond to the needs of healthcare professionals who are traveling on short-term assignments ...
(Date:8/23/2017)... ... 23, 2017 , ... MobilityWorks ®, the nation's largest ... 2017 Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka ... marking the twelfth year that the company has been included on the list. ...
(Date:8/23/2017)... MD (PRWEB) , ... August 23, 2017 , ... ... categories of the Golden Bridge Awards® - for Risk Management Solution Innovations and ... Secure Halo™ online platform released in 2017 and its DHS SAFETY Act-designated ...
(Date:8/22/2017)... ... August 22, 2017 , ... Nuvesse Skin ... and serums that perfectly fuse the beauty of naturally derived ingredients with the ... Beauty Expo on August 23rd & 24th in New York City. , Indie ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... recently spoke at a popular international aesthetics conference for medical professionals about the ... his patients’ health and his growing practice. , Dr. George K. Ibrahim ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... Ind. , Aug. 7, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the third quarter of 2017. ... be paid on or about October 27, 2017 to stockholders ... 22, 2017.  Future declarations of dividends are subject to approval ...
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
Breaking Medicine Technology: